Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery

被引:49
作者
Mildner, R. [1 ]
Hak, S. [2 ]
Parot, J. [2 ]
Hyldbakk, A. [2 ]
Borgos, S. E. [2 ]
Some, D. [3 ]
Johann, C. [1 ]
Caputo, F. [2 ]
机构
[1] Wyatt Technol, Hochstr 12a, D-56307 Dernbach, Germany
[2] SINTEF Ind, Dept Biotechnol & Nanomed, Trondheim, Norway
[3] Wyatt Technol, 6330 Hollister Ave, Santa Barbara, CA 93117 USA
关键词
Lipid-based nanoparticles; RNA delivery; Asymmetric-flow field-flow fractionation; Particle size; Particle concentration; Frit-inlet channel; Nanomedicine; NANOPARTICLES; SIZE; SEPARATION;
D O I
10.1016/j.ejpb.2021.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid-based nanoparticles for RNA delivery (LNP-RNA) are revolutionizing the nanomedicine field, with one approved gene therapy formulation and two approved vaccines against COVID-19, as well as multiple ongoing clinical trials. As for other innovative nanopharmaceuticals (NPhs), the advancement of robust methods to assess their quality and safety profiles?in line with regulatory needs?is critical for facilitating their development and clinical translation. Asymmetric-flow field-flow fractionation coupled to multiple online optical detectors (MDAF4) is considered a very versatile and robust approach for the physical characterisation of nanocarriers, and has been used successfully for measuring particle size, polydispersity and physical stability of lipid-based systems, including liposomes and solid lipid nanoparticles. However, the unique core structure of LNP-RNA, composed of ionizable lipids electrostatically complexed with RNA, and the relatively labile lipid-monolayer coating, is more prone to destabilization during focusing in MD-AF4 than previously characterised nanoparticles, resulting in particle aggregation and sample loss. Hence characterisation of LNP-RNA by MD-AF4 needs significant adaptation of the methods developed for liposomes. To improve the performance of MD-AF4 applied to LNP-RNA in a systematic and comprehensive manner, we have explored the use of the frit-inlet channel where, differently from the standard AF4 channel, the particles are relaxed hydrodynamically as they are injected. The absence of a focusing step minimizes contact between the particle and the membrane, reducing artefacts (e.g. sample loss, particle aggregation). Separation in a frit-inlet channel enables satisfactory reproducibility and acceptable sample recovery in the commercially available MD-AF4 instruments. In addition to slice-by-slice measurements of particle size, MD-AF4 also allows to determine particle concentration and the particle size distribution, demonstrating enhanced versatility beyond standard sizing measurements.
引用
收藏
页码:252 / 265
页数:14
相关论文
共 43 条
[1]   Characterization of sodium hyaluronate blends using frit inlet asymmetrical flow field-flow fractionation and multiangle light scattering [J].
Ali, Muhammad ;
Hwang, Euijin ;
Cho, Il-Hwan ;
Moon, Myeong Hee .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2012, 402 (03) :1269-1276
[2]  
[Anonymous], 213622018 ISOTS
[3]  
[Anonymous], WP2611- Application note: Characterization-of-nano-pharmaceuticals-with-FFFMALS-DLS
[4]  
[Anonymous], EUNCL-PCC022
[5]   Quantitation of influenza virus using field flow fractionation and multi-angle light scattering for quantifying influenza A particles [J].
Bousse, Tatiana ;
Shore, David A. ;
Goldsmith, Cynthia S. ;
Hossain, M. Jaber ;
Jang, Yunho ;
Davis, Charles T. ;
Donis, Ruben O. ;
Stevens, James .
JOURNAL OF VIROLOGICAL METHODS, 2013, 193 (02) :589-596
[6]   Measuring particle size distribution and mass concentration of nanoplastics and microplastics: addressing some analytical challenges in the sub-micron size range [J].
Caputo, F. ;
Vogel, R. ;
Savage, J. ;
Vella, G. ;
Law, A. ;
Della Camera, G. ;
Hannon, G. ;
Peacock, B. ;
Mehn, D. ;
Ponti, J. ;
Geiss, O. ;
Aubert, D. ;
Prina-Mello, A. ;
Calzolai, L. .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2021, 588 :401-417
[7]   Asymmetric-flow field-flow fractionation for measuring particle size, drug loading and (in)stability of nanopharmaceuticals. The joint view of European Union Nanomedicine Characterization Laboratory and National Cancer Institute - Nanotechnology Characterization Laboratory [J].
Caputo, F. ;
Mehn, D. ;
Clogston, J. D. ;
Roesslein, M. ;
Prina-Mello, A. ;
Borgos, S. E. ;
Gioria, S. ;
Calzolai, L. .
JOURNAL OF CHROMATOGRAPHY A, 2021, 1635
[8]   Measuring particle size distribution of nanoparticle enabled medicinal products, the joint view of EUNCL and NCI-NCL. A step by step approach combining orthogonal measurements with increasing complexity [J].
Caputo, F. ;
Clogston, J. ;
Calzolai, L. ;
Rosslein, M. ;
Prina-Mello, A. .
JOURNAL OF CONTROLLED RELEASE, 2019, 299 :31-43
[9]  
Caputo F, ZETA POTENTIAL DETER
[10]   Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles [J].
Caputo, Fanny ;
Arnould, Amandine ;
Bacia, Maria ;
Ling, Wai Li ;
Rustique, Emilie ;
Texier, Isabelle ;
Mello, Adriele Prina ;
Couffin, Anne-Claude .
MOLECULAR PHARMACEUTICS, 2019, 16 (02) :756-767